Violeta Panaviene

Santariskiu Str. 4
Vilnius, VL 08406, Lithuania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis.

Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis.

Journal: Rheumatology and therapy

Published: January 19, 2024

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.

Journal: Rheumatology (Oxford, England)

Published: August 19, 2022

ASSESSMENT OF PHYSICAL DEVELOPMENT OF PRESCHOOL CHILDREN OF THE REPUBLIC OF KAZAKHSTAN AND RETROSPECTIVE ANALYSIS OVER THE LAST 50 YEARS

ASSESSMENT OF PHYSICAL DEVELOPMENT OF PRESCHOOL CHILDREN OF THE REPUBLIC OF KAZAKHSTAN AND RETROSPECTIVE ANALYSIS OVER THE LAST 50 YEARS

Journal: Georgian medical news

Published: November 08, 2021

Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use.

Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use.

Journal: Rheumatology (Oxford, England)

Published: May 27, 2021

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis.

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 26, 2021

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial.

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial.

Journal: Arthritis research & therapy

Published: November 19, 2018

Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.

Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.

Journal: Arthritis research & therapy

Published: May 21, 2018

The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Journal: Rheumatology international

Published: December 22, 2017

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.

Journal: Annals of the rheumatic diseases

Published: September 01, 2016

Myocardial infarction associated with Kawasaki disease in adult man: case report and review of literature.

Myocardial infarction associated with Kawasaki disease in adult man: case report and review of literature.

Journal: The American journal of medicine

Published: August 01, 2014

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Journal: Annals of the rheumatic diseases

Published: May 23, 2013

Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in sexually intact girls with arthritides.

Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in sexually intact girls with arthritides.

Journal: Scandinavian journal of rheumatology

Published: July 19, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026